Kura Oncology Inc (KURA) — Cash Flow-to-Debt Ratio
Kura Oncology Inc (KURA) has a Cash Flow-to-Debt Ratio of -0.16x as of March 2026, meaning its operating cash flow of $-85.85 Million could theoretically repay 0% of its total liabilities ($544.67 Million) in one year. Check total reinvestment intensity of Kura Oncology Inc to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Kura Oncology Inc Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for Kura Oncology Inc across 17 annual periods. Also explore Kura Oncology Inc (KURA) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Kura Oncology Inc (2009–2025)
Year-by-year debt coverage analysis for Kura Oncology Inc. For market capitalisation and broader financial context, see KURA stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.11x | $-64.06 Million | $564.23 Million | ▼ -129.3% |
| 2024 | 0.39x | $134.32 Million | $346.52 Million | ▲ +116.0% |
| 2023 | -2.42x | $-124.82 Million | $51.66 Million | ▲ +20.9% |
| 2022 | -3.05x | $-110.06 Million | $36.03 Million | ▲ +19.8% |
| 2021 | -3.81x | $-104.55 Million | $27.44 Million | ▼ -98.1% |
| 2020 | -1.92x | $-69.83 Million | $36.31 Million | ▲ +18.5% |
| 2019 | -2.36x | $-54.76 Million | $23.19 Million | ▼ -3.8% |
| 2018 | -2.27x | $-48.66 Million | $21.39 Million | ▼ -27.8% |
| 2017 | -1.78x | $-28.44 Million | $15.99 Million | ▲ +9.1% |
| 2016 | -1.96x | $-25.35 Million | $12.95 Million | ▲ +43.7% |
| 2015 | -3.48x | $-17.93 Million | $5.16 Million | ▼ -656578.3% |
| 2014 | 0.00x | $-2.55K | $4.81 Million | ▲ +99.7% |
| 2013 | -0.18x | $-24.42K | $133.03K | ▲ +16.1% |
| 2012 | -0.22x | $-22.68K | $103.65K | ▲ +15.0% |
| 2011 | -0.26x | $-19.24K | $74.75K | ▲ +5.8% |
| 2010 | -0.27x | $-19.24K | $70.39K | ▲ +59.5% |
| 2009 | -0.68x | $-21.37K | $31.61K | — |